Literature DB >> 7745121

Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine.

M P Macheta1, L A Parapia, D R Gouldesbrough.   

Abstract

The case history of a man with refractory chronic lymphocytic leukaemia who developed acute renal failure following treatment with fludarabine is presented. A renal biopsy specimen showed features of mesangiocapillary glomerulonephritis, a rare occurrence in chronic lymphocytic leukaemia. The rapid cytocidal action of fludarabine may result in the development of renal glomerular lesions when used to treat a well differentiated B cell malignancy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7745121      PMCID： PMC502410          DOI： 10.1136/jcp.48.2.181

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  8 in total

1.  Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.

Authors:  A F List; T D Kummet; J D Adams; H G Chun
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

2.  [Nephrotic syndrome associated with B-cell chronic lymphocytic leukemia successfully treated with interferon-alpha].

Authors:  S Nakayama; H Yabe; K Nagai
Journal:  Rinsho Ketsueki       Date:  1990-12

3.  Nephrotic syndrome associated with chronic lymphocytic leukemia: an immunological and pathological study.

Authors:  G Touchard; J L Preud'homme; P Aucouturier; C Giraud; D Gouet; L Yver; D Patte
Journal:  Clin Nephrol       Date:  1989-02       Impact factor: 0.975

Review 4.  Mesangiocapillary glomerulonephritis associated with chronic lymphocytic leukaemia: a therapeutic dilemma.

Authors:  Z Korzets; A Elis; J Bernheim; M Ravid; J Bernheim
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

5.  Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.

Authors:  M J Keating; H Kantarjian; M Talpaz; J Redman; C Koller; B Barlogie; W Velasquez; W Plunkett; E J Freireich; K B McCredie
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

6.  Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas.

Authors:  B Moulin; P M Ronco; B Mougenot; A Francois; J P Fillastre; F Mignon
Journal:  Kidney Int       Date:  1992-07       Impact factor: 10.612

7.  A review of nephrotic syndrome associated with chronic lymphocytic leukemia.

Authors:  F D Seney; W R Federgreen; H Stein; M Kashgarian
Journal:  Arch Intern Med       Date:  1986-01

8.  Fludarabine phosphate for the treatment of low grade lymphoid malignancy.

Authors:  J S Whelan; C L Davis; S Rule; M Ranson; O P Smith; A B Mehta; D Catovsky; A Z Rohatiner; T A Lister
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640
  8 in total
  2 in total

Review 1.  Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors:  J C Adkins; D H Peters; A Markham
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 2.  Achieving optimal outcomes in chronic lymphocytic leukaemia.

Authors:  T J Hamblin
Journal:  Drugs       Date:  2001       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.